Skip to content
healthcare.dev

ORPHENADRINE CITRATE

NDC 72162-2020, ORPHENADRINE CITRATE, tablet, extended release, from Bryant Ranch Prepack.

Product NDC
72162-2020
Status
Listed
Labeler
Bryant Ranch Prepack
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040284
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72162-2020 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ORPHENADRINE CITRATE100 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
72162-2020-172162202001100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2020-1)
72162-2020-572162202005500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2020-5)
72162-2020-67216220200660 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2020-6)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1b4e379e-8051-421f-a0f4-ad9e6fb9476a

Use it

Look up 72162-2020 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72162-2020 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72162-2020. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.